InvestorsObserver
×
News Home

Will Gossamer Bio Inc (GOSS) Stay at the Top of the Healthcare Sector?

Monday, March 18, 2024 10:35 AM | InvestorsObserver Analysts

Mentioned in this article

Will Gossamer Bio Inc (GOSS) Stay at the Top of the Healthcare Sector?

Gossamer Bio Inc (GOSS) is around the top of the Healthcare sector according to InvestorsObserver. GOSS received an overall rating of 49, which means that it scores higher than 49% of stocks. Additionally, Gossamer Bio Inc scored a 93 in the Healthcare sector, ranking it higher than 93% of stocks in that sector.

Overall Score - 49
GOSS has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on GOSS!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Gossamer Bio Inc Stock Today?

Gossamer Bio Inc (GOSS) stock is lower by -8.22% while the S&P 500 is higher by 1.05% as of 10:34 AM on Monday, Mar 18. GOSS has fallen -$0.12 from the previous closing price of $1.46 on volume of 397,584 shares. Over the past year the S&P 500 is up 30.85% while GOSS is higher by 10.74%. GOSS lost -$1.18 per share the over the last 12 months. Click Here to get the full Stock Report for Gossamer Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App